ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
3 |
09:40 |
09:40 |
ASX - By Stock
|
783
|
356K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
10 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
783
|
356K
|
10
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
3 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
783
|
356K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
2 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
783
|
356K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
5 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
783
|
356K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
spnc
|
1.5K |
565K |
2 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
1.5K
|
565K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
'The most exciting new technology that has the most potential to be transformative to medicine' (Novartis CEO)
|
|
spnc
|
29 |
18K |
5 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
29
|
18K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
1 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
783
|
356K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
3 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
783
|
356K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
783
|
356K
|
6
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
3 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
783
|
356K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
783
|
356K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
135 |
50K |
3 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
135
|
50K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
5 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
783
|
356K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
2 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
783
|
356K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
135 |
50K |
0 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
135
|
50K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
135 |
50K |
9 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
135
|
50K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
4 billion market cap breached
|
|
spnc
|
15 |
7.2K |
6 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
15
|
7.2K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
4 billion market cap breached
|
|
spnc
|
15 |
7.2K |
1 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
15
|
7.2K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
4 billion market cap breached
|
|
spnc
|
15 |
7.2K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
15
|
7.2K
|
4
|
|
ASX - By Stock
|
TLX |
TLX became a Top 100 ASX company
|
|
spnc
|
4 |
2.8K |
16 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
4
|
2.8K
|
16
|
|
ASX - By Stock
|
TLX Biotech |
Re:
'The most exciting new technology that has the most potential to be transformative to medicine' (Novartis CEO)
|
|
spnc
|
29 |
18K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
29
|
18K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
7 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
783
|
356K
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
4 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
783
|
356K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
7 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
783
|
356K
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
5 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
783
|
356K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
0 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
783
|
356K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
783
|
356K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
381 |
114K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
381
|
114K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
381 |
114K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
381
|
114K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
783
|
356K
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
4 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
783
|
356K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
4 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
783
|
356K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
783
|
356K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
12 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
783
|
356K
|
12
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
14 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
783
|
356K
|
14
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
783
|
356K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
783
|
356K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
9 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
783
|
356K
|
9
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
5 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
783
|
356K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
783
|
356K
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
4 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
783
|
356K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
381 |
114K |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
381
|
114K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
6 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
783
|
356K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
135 |
50K |
10 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
135
|
50K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
381 |
114K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
381
|
114K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
135 |
50K |
5 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
135
|
50K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
381 |
114K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
381
|
114K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
783 |
356K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
783
|
356K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
381 |
114K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
381
|
114K
|
3
|
|